Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic retroperitoneal lymph node dissection after chemotherapy.

Michael A Palese1, Li-Ming Su, Louis R Kavoussi

  • 1Department of Surgery, Division of Urology, University of Maryland Medical System, Baltimore, Maryland, USA.

Urology
|July 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare urologic malignancies in solid organ transplant recipients.

Current urology·2026
Same author

Should Rezūm Water Vapor Thermal Therapy Be Considered for Large and Very Large Volume Benign Prostatic Hyperplasia?

Journal of the American College of Surgeons·2026
Same author

Back-Table Stone Removal During Renal Transplantation: A Systematic Review.

Clinical transplantation·2026
Same author

Factors influencing timely management and outcomes in testicular torsion.

Journal of pediatric urology·2026
Same author

A simplified algorithm for management of CP/CPPS and associated entities: A summary table for general urologists.

Current urology·2026
Same author

AI-enhanced micro-ultrasound improves detection of clinically significant prostate cancer at biopsy.

BJUI compass·2026
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
Same journal

Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.

Urology·2026
Same journal

Intractable Epistaxis and Severe Hypertension in a Young Woman.

Urology·2026
Same journal

A 53-Year-Old Man with Elevated PSA and a Cystic Pelvic Lesion.

Urology·2026
Same journal

Low-Grade, Papillary Bladder Tumors A plea for in-office fulguration.

Urology·2026
See all related articles

Laparoscopic retroperitoneal lymphadenectomy (RPLND) after chemotherapy is feasible but challenging. This procedure is best suited for select patients with limited residual disease and requires significant surgical expertise.

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Chemotherapy is a standard treatment for advanced germ cell tumors.
  • Residual retroperitoneal masses after chemotherapy require further management.
  • Laparoscopic retroperitoneal lymphadenectomy (RPLND) offers a minimally invasive approach.

Purpose of the Study:

  • To evaluate the feasibility, outcomes, and complications of laparoscopic RPLND post-chemotherapy.
  • To assess the safety and efficacy of this approach in managing residual retroperitoneal masses.

Main Methods:

  • Retrospective review of 7 patients undergoing laparoscopic RPLND after chemotherapy.
  • Patients had various germ cell tumors with residual masses or large pre-chemotherapy tumors.
  • Modified laparoscopic templates were utilized for lymph node dissection.

Related Experiment Videos

Main Results:

  • Successful completion of laparoscopic RPLND in 71.4% of patients; 28.6% required conversion to open surgery.
  • High overall complication rate (57.1%) with major complications in 42.8% of cases.
  • Histopathology revealed teratoma, necrotic tissue, or residual viable tumor in resected nodes.

Conclusions:

  • Laparoscopic RPLND is a feasible, albeit challenging, option following chemotherapy.
  • The procedure should be reserved for patients with limited residual disease.
  • Requires centers with substantial laparoscopic surgical expertise.